VANCOUVER, British Columbia, March 22, 2022 (GLOBE NEWSWIRE) -- Plant Veda Foods Ltd. (CSE:MILK) (OTC:PLVFF) (XFRA:A3CS6B) (the “Company” or “Plant Veda”), an award-winning dairy-alternative food manufacturer, attended the Naturals Products Expo West in California from March 8 to March 12. The Company was selected by the government of British Columbia, (“B.C.”) to help promote Canadian exports. The show had distributors, wholesalers and retailers from across the U.S. and around the globe. Plant Veda was able to identify new accounts and had a very successful show.
“We are proud to be among a very select group of B.C. companies that were chosen to partake in British Columbia’s Ministry of Jobs, Economic Recovery and Innovation (JERI) sponsored exhibition booth,” stated Sunny Gurnani, CEO of Plant Veda. “The Natural Products Expo West in Anaheim, California is the largest exhibition of its kind in North America that showcases the natural and organic industry. The show proved to be an excellent venue to introduce our superior product line to a whole new audience. Over the course of the show we attracted multiple new accounts and were able to display our products to tens of thousands of potential new consumers.”
“One of the things we learned from this Expo is that there is brand recognition for our products, our Lassi being Vegan was very popular, as well as our creamers, which contain no oils and are sweetened only with pure Canadian maple syrup. Lassi can be referred to as an ‘ancient smoothie’ and was indeed the first yogurt smoothie in the world. The concept originated in India thousands of years ago where yogurt was mixed with either fruits to make sweet lassi or herbs and spices to make salty lassi. The cooling properties and probiotics in Lassi gives a calming effect to the stomach and mind. I was very pleased with the positive feedback we received across our entire product line."
The Naturals Products Expo West in Anaheim was the first Expo West show since the start of the Covid-19 pandemic in 2019. It focused on the future of the estimated $300 billion USD natural and organic products industry. Attending shows such as Expo West is part of Plant Veda’s marketing initiatives for 2022. The Company intends to attend additional trade shows throughout the year to attract new customers and meet its sales objectives.
About Plant Veda (CSE:MILK) (OTC:PLVFF) (XFRA:A3CS6B)
Plant Veda Foods Ltd. has a mission to accelerate humanity’s shift to a plant-based lifestyle. We remain clear in our goals; to improve the environment and humanity’s overall health through plant-based consumption. Our Company has succeeded in creating award-winning plant-based dairy alternatives, continuing to shake up the dairy-free market by creating unique, one-of-a-kind products that leave our customers forgetting about dairy to begin with.
Learn more at www.PlantVeda.com.
To subscribe to updates about Plant Veda, visit www.PlantVeda.com/pages/investors.
To find Plant Veda products at a location near you, visit www.PlantVeda.com/pages/store-locations.
Facebook, Twitter, Instagram, YouTube
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/5a35a321-3713-4f7f-a500-635621c9a283
Company Contact:
Aaron Wong, Director
Email: Aaron@PlantVeda.com
Number: 778-840-9664
Investor Relations:
Email: Investors@PlantVeda.com
Number: 778-383-6737
Media Contact:
Email: Media@PlantVeda.com
Forward-Looking Statements
This news release contains “forward-looking information” within the meaning of applicable Canadian securities legislation. Often, but not always, forward-looking information and information can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur, or be achieved. Forward-looking information in this news release includes statements regarding new accounts or tens of thousands of potential consumers, but there is no assurance that any new consumers will buy our product of that the new accounts will order. The forward-looking information reflects management’s current expectations based on information currently available and are subject to a number of risks and uncertainties that may cause outcomes to differ materially from those discussed in the forward-looking information. Although the Company believes that the assumptions and factors used in preparing the forward-looking information are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed timeframes or at all. Factors that could cause actual results or events to differ materially from current expectations include: (i) adverse market conditions; (ii) changes to the growth and size of the dairy-alternative markets; and (iii) other factors beyond the control of the Company. The Company operates in a rapidly evolving environment. New risk factors emerge from time to time, and it is impossible for the Company’s management to predict all risk factors, nor can the Company assess the impact of all factors on Company’s business or the extent to which any factor, or combination of factors, may cause actual results to differ from those contained in any forward-looking information. The forward-looking information included in this news release are made as of the date of this news release and the Company expressly disclaims any intention or obligation to update or revise any forward-looking information whether as a result of new information, future events or otherwise, except as required by applicable law.
As each individual is different, the benefits, if any, of taking the Company’s products will vary from person to person. No claims or guarantees can be made as to the effects of the Company’s products on an individual’s health and well-being. The Company’s products are not intended to diagnose, treat, cure, or prevent any disease.
This news release may contain trademarked names of third-party entities (or their respective offerings with trademarked names) typically in reference to (i) relationships had by the Company with such third-party entities as referred to in this release and/or (ii) client/vendor/service provider parties whose relationship with the Company is/are referred to in this release. All rights to such trademarks are reserved by their respective owners or licensees.
